Breaking the Mold to Cut Pharmacy Spend

When a group plan serving 30,000 members set out to rethink its pharmacy benefit, they weren’t looking for a status quo PBM. They wanted control, transparency and real savings without sacrificing care or member experience.

Traditional PBM tactics had failed to deliver. Costs were climbing, GLP-1 utilization was unmanageable, and it was clear the old model wasn’t working. They needed a partner willing to do things differently. That led them to WellDyne.

From day one, WellDyne approached the challenge with clear intent: eliminate waste, apply clinical rigor and take bold action to drive savings. In the first year, the group cut pharmacy spend by 30% applying a combination of precise, high-impact strategies that transformed their benefit and provided a foundation for continued success.

Prior Authorizations

We didn’t hesitate to say no when it was the right thing to do. WellDyne applied evidence-based criteria, and prevented low-value prescribing, delivering over $9 million in savings while simultaneously ensuring members got the right drug at the best price.

Utilization Management

WellDyne leveraged our clinically sound formulary centered on biosimilars, generics and proven alternatives to high-cost medication. By guiding prescribers to appropriate options and supporting members in their adherence, we drove a 15-point improvement in formulary compliance and reduced spend by $1.9 million.

Specialty & Complex Care

We reined in specialty and chronic conditions through smarter use of copay programs and cost-effective alternatives. Delivering $1.8 million in savings and a 10% reduction in specialty drug spend.

GLP-1 Utilization

We didn’t rubber-stamp GLP-1s. Every prescription was carefully reviewed to ensure that use was appropriate. As a result, 36% of existing GLP-1 prescriptions were avoided, reducing diabetes spend and adding $2 million in savings to the bottom line.

This wasn’t just year-one savings. It was a complete reimagining of how pharmacy benefits should be managed. The result? A smarter, more sustainable benefit grounded in transparency and clinical integrity.

While ensuring responsible medication use, we never lost sight of the member. Proactive outreach and digital tools such as our texting platform, WellConnect, ensured members were informed, supported and guided, not blindsided. We minimized abrasion and preserved trust, creating positive outcomes for both the plan and member.

At WellDyne, we don’t just challenge the system. We have the guts to change it—and results that prove the difference.